Cover Story
Guest Editorial
By Issam El Naqa and Dana Rollison
Imagine a future where cancer patients are able to receive the treatment they precisely need and not the treatment that is prescribed to all.
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Canine cancers as models: We have barely tapped the full potential of comparative oncology
- Over three years as CEO, Karen Knudsen led ACS through COVID—and reversed the charity’s long slump
- FDA approves Anktiva for non-muscle-invasive bladder cancer
- Cold Spring Harbor and Northwell extend collaboration with $150M commitment